LEP and breast cancer: In addition to several reports indicating that high concentrations of circulating or local interstitial leptin are related to poor prognosis for breast cancer patients, some of the molecules involved with the leptin-induced pathways driving EMT, as previously studied in in vitro and in vivo models, were found in high levels in breast cancer patients tissue or serum samples.